ArticleFrontiers in allergy2024

Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal syndrome.

Michael N Saunders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.